Aug 8, 2023 • 8:00 am EDT Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Jul 31, 2023 • 8:00 am EDT Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
May 31, 2023 • 8:00 am EDT Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference
May 9, 2023 • 8:00 am EDT Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 1, 2023 • 8:00 am EDT Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on CRB-601 avβ8 Blocking Antibody at the New York Academy of Sciences' Frontiers in Cancer Immunotherapy Meeting
Apr 18, 2023 • 8:00 am EDT Corbus Pharmaceuticals Hosting Virtual 'Meet the Expert' Series: Blocking TGFβ with CRB-601--a New Play for an Old Target
Apr 17, 2023 • 8:30 am EDT Corbus Pharmaceuticals Presents Latest Pre-Clinical Data on CRB-601 at the 2023 American Association for Cancer Research Annual Meeting
Mar 14, 2023 • 4:35 pm EDT Corbus Pharmaceuticals Data on CRB-601 avβ8 Blocking Antibody Accepted for Presentation at the America Association for Cancer Research Annual Meeting
Mar 7, 2023 • 8:00 am EST Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update